Use of Oxandrolone to Promote Growth in Infants With HLHS
NCT04090697
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
34
Enrollment
OTHER
Sponsor class
Stopped
FDA withdrawal of Oxandrin NDA and generic ANDAs
Conditions
Hypoplastic Left Heart
Congenital Heart Disease
Interventions
DRUG:
Oxandrolone
Sponsor
Carelon Research